Eris Lifesciences Pays Interest on Outstanding Non-convertible Debentures
Eris Lifesciences Ltd has completed the routine interest servicing against its outstanding non-convertible debentures (NCDs). The company made these payments across two series of NCDs on June 8, 2026.The interest payment relates to a record date of May 24, 2026, for both tranches.Interest Payment Details by Debenture Series
Eris Lifesciences provided comprehensive details regarding the servicing of interest payments for its outstanding debentures. The transactions are detailed in the following tables:Interest Payments on NCD (ISIN INE406M08029)ParticularsAmount (Rs. In crore)Issue Size625Interest Amount Due54.56Gross Interest Paid54.56Tax...